FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 2172817 · Received July 22, 2011

Report

Report Number
2124215-2011-10263
Event Type
Injury
Date Received
July 22, 2011
Date of Event
June 8, 2011
Report Date
June 8, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT AT THE POST-OPERATION CHECK FOLLOWING AN UPGRADE PROCEDURE, THE SHOCK IMPEDANCE MEASUREMENT WAS GREATER THAN 125 OHMS. A REVISION PROCEDURE WAS PERFORMED WHERE IT WAS NOTED THAT THE PROXIMAL PIN ON THE RIGHT VENTRICULAR (RV) LEAD WAS NOT ADEQUATELY SECURED INTO THE HEADER OF THE DEVICE. THE PHYSICIAN SECURED THE PIN PROPERLY, PLACED THE DEVICE BACK INTO THE POCKET AND REPEATED ALL TESTS. ALL MEASUREMENTS WERE SATISFACTORY AND THE DEVICE AND RV LEAD REMAIN IMPLANTED IN THE PATIENT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 66 YR Hospitalization| L| R E110| 0125| 1850| T175| 4135| 1740